Abstract-The relationship between the poststroke blood pressure (BP) and functional outcomes in patients with acute ischemic stroke is still controversial. The aim of the present study was to elucidate the impact of the poststroke BP on the clinical outcomes of acute ischemic stroke. Among the patients in the Fukuoka Stroke Registry, 1874 patients with first-ever acute ischemic stroke (within 24 hours of onset) who had been functionally independent before onset were prospectively enrolled in the present study. The poststroke BP levels were defined as the average values during the 48 hours after onset. The study outcomes were a good neurological recovery, neurological deterioration, and a poor functional outcome. The higher poststroke BP levels were significantly associated with a lower probability of a good neurological recovery and elevated risks of neurological deterioration and a poor functional outcome after adjusting for potential confounding factors. The multivariate-adjusted odds ratios (95% confidence interval) in the highest quintile of systolic BP (versus the lowest quintile as a reference) were 0.51 (0.37-0.71) for a good neurological recovery, 1.92 (1.15-3.27) for neurological deterioration, and 2.51 (1.69-3.74) for a poor functional outcome. Similar associations were observed when we applied the poststroke diastolic BP or pulse pressure. No evidence of the J-curve phenomenon was observed for each association. These results suggest that a high poststroke BP was significantly associated with unfavorable clinical outcomes in patients with acute ischemic stroke. There was no evidence of the J-curve phenomenon between the poststroke BP levels and the clinical outcomes. (Hypertension. 2014;63:00-00.) • Online Data Supplement
H ypertension is one of the most common and important risk factors for the development of ischemic stroke. When stroke occurs, the blood pressure (BP) often rises because of various factors, such as psychological stress, pain, elevated intracranial pressure, urinary retention, and hypoxemia. 1 BP after acute ischemic stroke may also be elevated because of impaired autoregulation or compensatory efforts to maximize cerebral perfusion to ischemic brain tissue. Therefore, the poststroke BP is high in most patients with acute ischemic stroke. Such a hypertensive response is transient and the BP spontaneously decreases with time. [2] [3] [4] [5] A high BP is beneficial to maintain the blood flow in the ischemic brain, but it may be detrimental with regard to the brain edema and hemorrhagic transformation. Although a number of studies have reported a relationship between the poststroke BP and clinical outcomes in patients with ischemic stroke, the results are still conflicting. A higher poststroke BP was associated with unfavorable clinical outcomes in some studies 6, 7 but with favorable outcomes in other studies. 8, 9 Interestingly, several studies reported a J-or U-shaped association between the poststroke BP and the clinical outcomes. [10] [11] [12] [13] We performed a large-scale prospective investigation on the BP in the hyperacute stage and clinical outcomes in our cohort of patients with acute ischemic stroke. The aim of the present study was to elucidate how the poststroke BP levels are associated with the clinical outcomes after acute ischemic stroke.
Registry. Written informed consent was obtained from each patient or his/her proxy. The study design was approved by the ethics review board at each center. Stroke was defined as a neurological impairment of sudden onset lasting for >24 hours. The stroke subtypes were confirmed by brain imaging, including computed tomography and MRI, and were classified into ischemic and hemorrhagic strokes. Ischemic stroke was further classified into 4 subtypes: lacunar infarction, atherothrombotic infarction, cardioembolic infarction, and the unclassified subtype, according to the Classification of Cerebrovascular Disease III proposed by the National Institute of Neurological Disorders and Stroke, 16 as well as on the basis of the diagnostic criteria of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) study 17 and Cerebral Embolism Task Force. 18 The unclassified subtype included ischemic stroke with other determined pathogeneses and that with an undetermined pathogenesis.
Participants in the Present Study
During the period from June 2007 to July 2011, 5146 cases were prospectively registered in the Fukuoka Stroke Registry database, of which 4345 cases were ischemic strokes. In the present study, cases of recurrent stroke, cases with impaired activities of daily living before stroke onset, and cases of hospitalization for >24 hours after onset were excluded ( Figure) . Finally, 1874 patients, with first-ever ischemic stroke within 24 hours of onset who had been functionally independent before the stroke onset, were analyzed for neurological recovery and deterioration during hospitalization. Similarly, 1790 patients were analyzed for the functional outcome at 3 months after the stroke.
Measurement of BP
The BP was prospectively measured on admission and then at 10:00, 14:00, and 18:00 during the first 48 hours in a supine position. Trained nurses measured the BP at the upper arm using an automated cuff or a mercury or aneroid sphygmomanometer (http://hyper.ahajournals.org). The pulse pressure (PP) was calculated as the difference between the systolic BP (SBP) and diastolic BP (DBP) for each measurement. The poststroke SBP, DBP, and PP were defined as the averaged values of 7 measurements during the 48 hours after onset, and each BP parameter was classified into 5 quintiles. The acute BP was managed and treated on a best practice basis by each physician, mainly according to the Japanese Guidelines for the Management of Stroke published in 2004 or 2009. 19, 20 In the present study, 996 patients (53.1%) had been treated with antihypertensives before onset. Except for 424 patients (22.6%) who required continuous medications for coexisting cardiovascular diseases, the antihypertensive treatment was discontinued and was not reinitiated unless the poststroke BP exceeded 180 mm Hg in patients with thrombolytic therapy and 220 mm Hg in patients without thrombolytic therapy.
Clinical Assessment
Hypertension was defined as a SBP ≥140 mm Hg or a DBP ≥90 mm Hg in the chronic stage or as a medical history and preadmission treatment with antihypertensive drugs. A diagnosis of diabetes mellitus was determined by the diagnostic criteria of the Japan Diabetes Society 21 in the chronic stage or based on a medical history of diabetes mellitus. Dyslipidemia was defined as either a lowdensity lipoprotein-cholesterol level ≥3.62 mmol/L, high-density lipoprotein-cholesterol level <1.03 mmol/L, triglycerides ≥1.69 mmol/L, or preadmission use of a cholesterol-lowering drug. Atrial fibrillation was diagnosed on the basis of the electrocardiographic findings on admission or during hospitalization. The body mass index was measured on admission. The blood glucose level was also measured, and the estimated glomerular filtration rate was calculated on admission. The estimated glomerular filtration rate was determined using the equation proposed by the Japanese Society of Nephrology as follows: estimated glomerular filtration rate (mL/min per 1 22 Thrombolytic therapy was defined as intravenous or intra-arterial administration of thrombolytic agents, such as recombinant tissue-type plasminogen activator and urokinase, in the acute phase of the stroke. Acute infections were defined as any infections, such as pneumonia, urinary tract infection, or sepsis, that occurred during the hospitalization.
Assessment of the Clinical Course and Outcome
The neurological severity on admission and at discharge was assessed by the National Institutes of Health Stroke Scale (NIHSS) score, and the functional outcome was assessed by the modified Rankin Scale (mRS) at 3 months after the onset. The NIHSS and mRS were assessed by trained stroke neurologists during hospitalization. The evaluation of the mRS at the 3-month time point was done by trained and certified research nurses on the basis of a standardized structured questionnaire that had been validated in a previous study 23 to minimize the inter-rater variability. The outcomes in the present study were a good neurological recovery (≥4-point decrease in the NIHSS during hospitalization or 0 points at discharge), neurological deterioration (≥2-point increase in the NIHSS during hospitalization), and a poor functional outcome (disability or death [mRS scale, ≥2] at 3 months after the stroke onset).
Statistical Analysis
We compared the poststroke BP values among the NIHSS quartile groups or among stroke subtypes by linear regression and ANOVA. The age-and sex-adjusted and multivariate-adjusted odds ratios and their 95% confidence intervals were assessed by a logistic regression analysis. C-statistics were calculated to assess the predictive value of the multivariate model using the SBP, DBP, or PP for each outcome. Tests for linearity or nonlinearity were performed by comparing the model that assumed a linear association with the model that included 4 dummy variables for the quintile groups. The statistical analysis was performed using the JMP version 8 software program (SAS Institute Inc, Cary, NC). P values <0.05 were considered to be statistically significant. Table 1 shows the characteristics of the 1874 patients who were included in this study. Their mean age was 70 years, and 37.6% were women. Among these patients, 76.0% had hypertension, and 33.4% received antihypertensive treatment during the 3 days after admission. During the study period, antihypertensive agents were administered intravenously to 124 patients (calcium channel blockers in 68 patients, nitroglycerin in 44 patients, and diuretics in 12 patients). Seventy-nine patients received transdermal nitroglycerin. Oral antihypertensives were administered to 742 patients (calcium channel The mean poststroke BP values are shown according to the baseline NIHSS levels and ischemic stroke subtypes in Tables 2 and 3 , respectively. Higher NIHSS levels on admission were associated with elevated SBP and PP levels and decreased DBP levels (all P<0.05 for the trend). Compared with patients with cardioembolic stroke, patients with other subtypes tended to have a higher BP. Table 4 shows the relationship between the poststroke BP levels and a good neurological recovery during the hospitalization. The higher poststroke SBP levels were significantly and continuously associated with a lower probability of good neurological recovery after adjusting for age and sex. This association was unchanged even after multiple adjustments for potential confounding factors. Similarly, higher DBP and PP levels were significantly and inversely associated with a good neurological recovery during the hospitalization. All associations were linear (all P>0.05 for linearity), and no evidence of the J-curve phenomenon was observed.
Results

Background of the Patients
Association Between the Poststroke BP Levels and Clinical Outcomes
The effect of the poststroke BP levels on the risk of neurological deterioration during the hospitalization is summarized in Table 5 . Higher levels of poststroke SBP, DBP, and PP were significantly associated with an elevated risk of neurological deterioration even after the multivariate adjustments. All associations were linear (all P>0.3 for linearity), and no evidence of the J-curve phenomenon was observed.
The association of the poststroke BP levels with a poor functional outcome is shown in Table 6 . The poststroke BP levels and functional outcomes at 3 months showed significant and positive correlations. Again, all associations were linear (all P>0.07 for linearity in the multivariate analyses), and no clear evidence of a J-curve association was suggested. These trends were unchanged when a poor functional outcome was defined as more severe disability or death (mRS scale, ≥3) at 3 months after the stroke onset (data not shown).
We calculated C-statistics in which each BP component was separately included in the multivariate models. The C-statistics for a good neurological recovery were 0.663 for the SBP, 0.659 for the DBP, and 0.653 for the PP. Those for neurological deterioration were 0.792 for the SBP, 0.787 for the DBP, and 0.781 for the PP, and those for a poor functional outcome were 0.853 for the SBP, 0.850 for the DBP, and 0.849 for the PP.
For the sensitivity analyses, we further analyzed the associations between the poststroke BP levels and clinical outcomes after stroke in the cohort with or without treatment with antihypertensive agents during first 3 days after onset. As a result, the trend in the association between the poststroke BP and each study outcome was essentially unchanged (Tables S2-S4 in the online-only Data Supplement). In addition, the associations were also investigated in subpopulations of patients with atherothrombotic infarction compared with those with other types of infarction. A similar trend in the association was still observed in both subpopulations (Tables S5-S7) . eGFR indicates estimated glomerular filtration rate; NIHSS, National Institutes of Health Stroke Scale; and IQR, interquartile range.
*Antihypertensive treatment during the 3 days after admission. 
The NIHSS was categorized into 4 groups (Q1-Q4) according to the quartile. Values are the mean±SD. BP indicates blood pressure; DBP, diastolic blood pressure; NIHSS, National Institutes of Health Stroke Scale; PP, pulse pressure; and SBP, systolic blood pressure. 
Discussion
The present study showed that an elevated poststroke BP was associated with a lower probability of neurological recovery and higher risks of neurological deterioration and a poor functional outcome in patients with acute ischemic stroke. These associations were unchanged irrespective of antihypertensive treatment during the acute phase or atherothrombotic infarction caused by large-vessel occlusions or stenoses. Although an early elevation of the BP is very common in patients with acute ischemic stroke, our findings suggested that a high BP itself may be associated with the unfavorable clinical outcomes after acute ischemic stroke. Previous studies reported conflicting results about the relationship between the poststroke BP levels and the clinical outcomes in patients with ischemic stroke. Some studies reported that a high poststroke BP was associated with a poor functional outcome. 6, 7 In contrast, other studies suggested that a high poststroke BP was favorable with regard to the outcome. 8, 9 Still the other studies suggested the presence of a J-or U-curve phenomenon between the poststroke BP and the functional outcome. [10] [11] [12] A metaregression analysis indicated that large falls, as well as large increases, in BP were associated with poorer outcomes. 13 The present study showed that the clinical outcomes became progressively poorer as the level of poststroke BP increased. We found no clear evidence of a J-curve relationship between the poststroke BP levels and the clinical outcomes.
We conducted a large-scale prospective investigation on the relationship between the poststroke BP and clinical outcomes in patients with acute ischemic stroke. The previous largescale studies were predominantly derived from retrospective subanalyses of randomized controlled trials. 6, 7, 11 These studies were not designed to investigate the effect of the poststroke BP on the clinical outcomes but to elucidate the efficacy and safety of a certain treatment in a prespecified population. Vemmos et al 12 investigated the registry data from 1428 patients; however, they included patients with both ischemic and hemorrhagic stroke. Similarly, another systematic review on this topic analyzed data from patients with both ischemic and hemorrhagic stroke (5 studies of ischemic stroke, 11 studies of primary intracerebral hemorrhage, and 16 studies of mixed types). Moreover, the timing and method of BP measurement, the BP data (continuous or dichotomous), prestroke dependency, and outcome measures were not uniform. 24 Such variability may have resulted in the conflicting results.
The presence of a U-curve phenomenon between the BP and the outcome was suggested to be caused by the use of The multivariate model included age, sex, body mass index, hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, blood glucose on admission, estimated glomerular filtration rate, ischemic stroke subtype (atherothrombotic or nonatherothrombotic infarction), infarct area (anterior or posterior circulation), thrombolytic therapy, acute infections, oral or intravenous antihypertensive agents administered during the 3 days after admission and the baseline National Institutes of Health Stroke Scale. BP indicates blood pressure; CI, confidence interval; DBP, diastolic blood pressure; OR, odds ratio; PP, pulse pressure; and SBP, systolic blood pressure. by guest on April 30, 2017 http://hyper.ahajournals.org/ Downloaded from antihypertensive drugs. 25 However, other studies showed that controlling high BP with antihypertensives or the continuation of antihypertensive drugs was not associated with an increase in the number of adverse events in patients with acute stroke. 26, 27 In a recent randomized, placebo-controlled, double-blind trial, the Scandinavian Candesartan Acute Stroke Trial (SCAST), it was reported that careful BP-lowering treatment with the angiotensin-receptor blocker, candesartan, was not only not beneficial but also harmful to the clinical outcomes in patients with acute stroke. 28 Further, a subanalysis of the SCAST demonstrated that a large decrease or an increase/no change in the SBP increased the risk of early adverse events. 29 In the present study, 53% of the patients had been treated with antihypertensives before the onset of stroke. However, the antihypertensive treatment was discontinued to avoid excessive reduction of the poststroke BP unless it rose to an extremely high level. Under such conditions, a higher BP was associated with unfavorable clinical outcomes of patients with acute ischemic stroke, irrespective of the antihypertensive treatment. Because the causality between the poststroke BP and the clinical outcomes is still unclear, further studies are needed to elucidate how the poststroke BP should be managed in the acute phase of ischemic stroke.
The mechanisms underlying the association of poststroke hypertension with the clinical outcomes are currently unknown. In this study, a poststroke high BP was associated with all unfavorable outcomes, and each BP component had comparable C-statistics for all outcomes. A high BP may disrupt the blood brain barrier, leading to the exacerbation of brain edema and aggravation of hemorrhagic infarction. Another possibility is that the poststroke BP remains high to maintain the perfusion pressure in the distal portion of the occluded cerebral arteries. A previous study showed that the BP at 12 hours after thrombolytic therapy was higher in patients with inadequate recanalization than in those with adequate recanalization. 30 In addition, the SBP was shown to be significantly higher in patients with incomplete or absent recanalization than in those with complete recanalization after thrombolytic therapy. 31 Therefore, the BP may be elevated to increase the perfusion pressure in patients with occluded cerebral arteries, which would underlie the association between a poststroke high BP and poor functional outcomes.
This study had some strengths. The number of subjects was large, and their characteristics were homogeneous in terms of first-ever ischemic stroke and no prestroke functional independency. Data were prospectively collected, and possible The multivariate model included age, sex, body mass index, hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, blood glucose on admission, estimated glomerular filtration rate, ischemic stroke subtype (atherothrombotic or nonatherothrombotic infarction), infarct area (anterior or posterior circulation), thrombolytic therapy, acute infections, oral or intravenous antihypertensive agents administered during the 3 days after admission and the baseline National Institutes of Health Stroke Scale. BP indicates blood pressure; CI, confidence interval; DBP, diastolic blood pressure; OR, odds ratio; PP, pulse pressure; and SBP, systolic blood pressure. by guest on April 30, 2017 http://hyper.ahajournals.org/ Downloaded from confounding factors were adjusted in multivariate analysis. This study investigated data on Japanese patients, racially homogeneous Asians, whereas the previous studies were performed in Western countries. There are also some limitations to this study that should be kept in mind when interpreting the results. We determined the mean BP levels using several measurements and did not continuously monitor the BP during hospitalization. Therefore, possible measurement error might have resulted in the underestimation, as well as overestimation, of the association between the poststroke BP levels and the study outcomes. There may have been a selection bias because this study included only inpatients and was not from a nationwide study. Moreover, most patients had minor strokes, and thus, the results may not be generalized to patients with moderate or severe strokes.
Perspectives
Our data imply that a higher poststroke BP is associated with neurological deterioration, a poor neurological recovery, and a poor functional outcome at 3 months in patients with acute ischemic stroke. There was no evidence of the J-curve association between the poststroke BP levels and clinical outcomes. These findings did not change essentially even after excluding the patients with antihypertensive treatment. However, these findings do not encourage the use of antihypertensive agents for patients with acute ischemic stroke. Further studies are required to elucidate the causality between the BP and the clinical outcomes after acute ischemic stroke.
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Supplemental Methods
Measurement of BP
The BP was measured irrespective of the side depending on the patients' conditions, such as paralysis and intravenous infusion. If the BP reading was different between the sides, the BP value on the side with the higher reading was adopted. The mean values of each post-stroke BP component in the included and excluded patients are shown in Supplemental Table S1. In the 1874 patients included in this study, the number of BP measurements was seven in 562 patients (30.0%), six in 626 patients (33.4%), five in 613 patients (32.7%), four in 65 patients (3.5%), three in four patients (0.2%), and once in four patients (0.2%).
Statistical analysis
The multivariate-adjusted odds ratios (OR) and their 95% confidence intervals (CI) were assessed by a logistic regression analysis. Tests for linearity or nonlinearity were performed by comparing the model which assumed a linear association with the model which included four dummy variables for the quintile groups. The multivariate model in Tables S2-S4 included age, sex, body mass index, hypertension, diabetes, dyslipidemia, atrial fibrillation, blood glucose on admission, estimated glomerular filtration rate, ischemic stroke subtype (atherothrombotic or non-atherothrombotic infarction), infarct area (anterior or posterior circulation), thrombolytic therapy, acute infections and the baseline NIHSS. The multivariate model in Tables S5-S7 included age, sex, body mass index, hypertension, diabetes, dyslipidemia, atrial fibrillation, blood glucose on admission, estimated glomerular filtration rate, infarct area (anterior or posterior circulation), thrombolytic therapy, acute infections, oral or intravenous antihypertensive agents administered during the three days after admission and the baseline NIHSS. The statistical analysis was performed using the JMP version 8 software program (SAS Institute Inc., Cary, NC, USA). P values <0.05 were considered to be statistically significant.
The participating hospitals in the Fukuoka Stroke Registry (FSR)
The participating hospitals in the FSR are located in three urban cities in Fukuoka Prefecture.
There is one university hospital (Kyushu University Hospital) and three community hospitals 
